AstraZeneca AZN.L on Thursday forecast 2021 revenue growth after the COVID-19 vaccine developer beat analyst's estimates for fourth-quarter product sales, as a wide range of therapies helped cushion the hit from the pandemic.
https://www.nasdaq.com/articles/astrazeneca-forecasts-2021-growth-reports-q4-sales-beat-2021-02-11
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.